On behalf of the German Association of Cardiologists in Private Practice (BNK) the Steering Committee of the QuIK Registry reports the results 2010 to 2012 of the voluntary Quality Assurance in Invasive Cardiology (QuIK) and compares them to other data collections. More than 70 % of diagnostic (LHC) and therapeutic (PCI) cardiac catheterization procedures in private practice were entered into the registry. Altogether 225,756 LHC and 63,951 PCI were documented over the three years period. In these years age of patients and percentage of acute coronary syndromes increased as well in LHC as in PCI while consumption of dye solution and application of radiation dose decreased. In PCI the rate of 3-vessel coronary artery disease is still continuously rising. These parameters prove the increasing complexity of the cases. By implemented standardized external auditing (monitoring) to guarantee validity of the data QuIK remains a worldwide unique quality assurance project in cardiology. On a stable data base over all together 17 years the QuIK Registry shows the reality of every day cardiologic care in catheterization laboratories beyond selected study populations as well as a reliable feasibility of internal and external quality assurance.

On behalf of the German Association of Cardiologists in Private Practice (BNK) the Steering Committee of the QuIK Registry reports the results 2010 to 2012 of the voluntary Quality Assurance in Invasive Cardiology (QuIK) and compares them to other data collections. More than 70 % of diagnostic (LHC) and therapeutic (PCI) cardiac catheterization procedures in private practice were entered into the registry. Altogether 225,756 LHC and 63,951 PCI were documented over the three years period. In these years age of patients and percentage of acute coronary syndromes increased as well in LHC as in PCI while consumption of dye solution and application of radiation dose decreased. In PCI the rate of 3-vessel coronary artery disease is still continuously rising. These parameters prove the increasing complexity of the cases. By implemented standardized external auditing (monitoring) to guarantee validity of the data QuIK remains a worldwide unique quality assurance project in cardiology. On a stable data base over all together 17 years the QuIK Registry shows the reality of every day cardiologic care in catheterization laboratories beyond selected study populations as well as a reliable feasibility of internal and external quality assurance.

On behalf of the German Association of Cardiologists in Private Practice (BNK) the Steering Committee of the QuIK Registry reports on the results of the voluntary quality assurance in invasive cardiology for the years 2006 to 2009 and compares them to other data collections. More than 70% of diagnostic (LHC) and therapeutic (PCI) cardiac catheterization procedures in private practice were entered into the registry. Altogether 315,174 LHC and 89,746 PCI were documented over the four year period. In these four years age of patients and percentage of acute coronary syndromes increased as well in LHC as in PCI while application of radiation dose and consumption of dye solution decreased. In PCI the rate of 3-vessel coronary artery disease is still rising, continuously. By implemented standardized external auditing (monitoring) to guarantee validity of the data, QuIK remains a worldwide unique quality assurance project in cardiology. On a stable data base over all together 14 years the QuIK Registry shows the reality of every day cardiologic care in catheterization laboratories beyond selected study populations.

On behalf of the German Association of Cardiologists in Private Practice (BNK) the Steering Committee of the QuIK Registry reports on the results of the voluntary quality assurance in invasive cardiology for the years 2006 to 2009 and compares them to other data collections. More than 70% of diagnostic (LHC) and therapeutic (PCI) cardiac catheterization procedures in private practice were entered into the registry. Altogether 315,174 LHC and 89,746 PCI were documented over the four year period. In these four years age of patients and percentage of acute coronary syndromes increased as well in LHC as in PCI while application of radiation dose and consumption of dye solution decreased. In PCI the rate of 3-vessel coronary artery disease is still rising, continuously. By implemented standardized external auditing (monitoring) to guarantee validity of the data, QuIK remains a worldwide unique quality assurance project in cardiology. On a stable data base over all together 14 years the QuIK Registry shows the reality of every day cardiologic care in catheterization laboratories beyond selected study populations.

QuIK is the German acronym for QUalityAssurance in Invasive Cardiology.It describes the continuous project of an electronic data collectionin Cardiac catheterization laboratories all over Germany. Mainlymembers of the German Society of Cardiologists in Private Practice(BNK) participate in this computer based project. Since 1996 dataof diagnostic and interventional procedures are collected and sendto a registry-center where a regular benchmarking analysis of the resultsis performed. Part of the project is a yearly auditing process includingan on-site visit to the cath lab to guarantee for the reliabilityof information collected. Since 1996 about one million procedureshave been documented.

QuIK is the German acronym for QUality Assurance in Invasive Cardiology. It describes the continuous project of an electronic data collection in Cardiac catheterization laboratories all over Germany. Mainly members of the German Society of Cardiologists in Private Practice (BNK) participate in this computer based project. Since 1996 data of diagnostic and interventional procedures are collected and send to a registry-center where a regular benchmarking analysis of the results is performed. Part of the project is a yearly auditing process including an on-site visit to the cath lab to guarantee for the reliability of information collected. Since 1996 about one million procedures have been documented.

Aims Modern pacemakers provide a large amount of diagnostic data. Given the limited time available during a pacemaker follow-up visit essential information may be overlooked. This registry was conducted to assess the utility of an expert system that analyses the diagnostic data collected by an implanted pacing device and notifies and advises the physician about suspected technical issues and arrhythmias that need further attention.Methods Patients with various standard indications for pacing were included in this registry and received single or dual chamber pacemakers. Data were collected and analysed by the expert system during at least two subsequent follow-up visits. The evaluation of this system focused on data obtained from patients with a dual chamber pacing device without prior history of atrial arrhythmias.Results A total number of 239 patients without prior history of atrial tachyarrhythmias were included in this analysis. Atrial tachyarrhythmias were detected in 73 (31%) of these patients. The highest incidence of newly detected arrhythmias occurred in the group of patients with high-degree AV block and VDD pacemakers. Furthermore, newly detected arrhythmias predominantly occurred in the period shortly after implantation. Device programming suggestions by the expert system were adopted in 30% of the cases. Following detection of atrial tachyarrhythmias by the expert system, pharmacological management was adjusted at 71% of the first follow-up visits and at 27% of later follow-up visits.Conclusion Results of this registry show that this expert system provides a valuable tool for the detection of atrial tachyarrhythmias during pacemaker follow-up visits. (c) 2005 The European Society of Cardiology. Published by Elsevier Ltd. All rights reserved.

Drug Prescribing for Patients with Chronic Kidney Disease in General Practice: a Cross-Sectional Study